430 related articles for article (PubMed ID: 25826420)
1. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
[TBL] [Abstract][Full Text] [Related]
2. A clinically useful risk-score for chronic kidney disease in HIV infection.
Mocroft A; Lundgren J; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Heuhaus J; Fux C; Moranne O; Morlat P; Johnson M; Ryom L;
J Int AIDS Soc; 2014; 17(4 Suppl 3):19514. PubMed ID: 25394023
[TBL] [Abstract][Full Text] [Related]
3. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
Dietrich LG; Barceló C; Thorball CW; Ryom L; Burkhalter F; Hasse B; Furrer H; Weisser M; Steffen A; Bernasconi E; Cavassini M; de Seigneux S; Csajka C; Fellay J; Ledergerber B; Tarr PE
Clin Infect Dis; 2020 Feb; 70(5):890-897. PubMed ID: 30953057
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
Mills AM; Schulman KL; Fusco JS; Brunet L; Hsu R; Beyer A; Prajapati G; Mounzer K; Fusco GP
HIV Med; 2020 May; 21(5):299-308. PubMed ID: 31985887
[TBL] [Abstract][Full Text] [Related]
7. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
Han WM; Bijker R; Chandrasekaran E; Pujari S; Ng OT; Ly PS; Lee MP; Van Nguyen K; Chan YJ; Do CD; Choi JY; Chaiwarith R; Merati TP; Kiertiburanakul S; Azwa I; Khusuwan S; Zhang F; Gani YM; Tanuma J; Sangle S; Ditangco R; Yunihastuti E; Ross J; Avihingsanon A;
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):489-497. PubMed ID: 33136750
[TBL] [Abstract][Full Text] [Related]
8. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
Ryom L; Mocroft A; Kirk O; Worm SW; Kamara DA; Reiss P; Ross M; Fux CA; Morlat P; Moranne O; Smith C; Lundgren JD;
J Infect Dis; 2013 May; 207(9):1359-69. PubMed ID: 23382571
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
Boyd MA; Mocroft A; Ryom L; Monforte AD; Sabin C; El-Sadr WM; Hatleberg CI; De Wit S; Weber R; Fontas E; Phillips A; Bonnet F; Reiss P; Lundgren J; Law M
PLoS Med; 2017 Nov; 14(11):e1002424. PubMed ID: 29112958
[TBL] [Abstract][Full Text] [Related]
10. Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.
Morlat P; Vivot A; Vandenhende MA; Dauchy FA; Asselineau J; Déti E; Gerard Y; Lazaro E; Duffau P; Neau D; Bonnet F; Chêne G;
PLoS One; 2013; 8(6):e66223. PubMed ID: 23776637
[TBL] [Abstract][Full Text] [Related]
11. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons.
Ryom L; Mocroft A; Kirk O; Ross M; Reiss P; Fux CA; Morlat P; Moranne O; Smith C; El-Sadr W; Law M; Lundgren JD
AIDS; 2014 Jan; 28(2):187-99. PubMed ID: 24361680
[TBL] [Abstract][Full Text] [Related]
12. Does first-line antiretroviral regimen impact risk for chronic kidney disease whatever the risk group?
Flandre P; Pugliese P; Allavena C; Isnard Bagnis C; Cuzin L;
AIDS; 2016 Jun; 30(9):1433-8. PubMed ID: 26891036
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
[TBL] [Abstract][Full Text] [Related]
14. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.
Joshi K; Boettiger D; Kerr S; Nishijima T; Van Nguyen K; Ly PS; Lee MP; Kumarasamy N; Wong W; Kantipong P; Cuong DD; Kamarulzaman A; Choi JY; Zhang F; Chaiwarith R; Ng OT; Kiertiburanakul S; Sim BLH; Merati TP; Yunihastuti E; Ditangco R; Ross J; Pujari S
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1209-1216. PubMed ID: 30246898
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.
Calza L; Sachs M; Colangeli V; Borderi M; Granozzi B; Malosso P; Comai G; Corradetti V; La Manna G; Viale P
Clin Exp Nephrol; 2019 Nov; 23(11):1272-1279. PubMed ID: 31327092
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
[TBL] [Abstract][Full Text] [Related]
17. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF;
HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988
[TBL] [Abstract][Full Text] [Related]
18. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study.
Ryom L; Dilling Lundgren J; Reiss P; Kirk O; Law M; Ross M; Morlat P; Andreas Fux C; Fontas E; De Wit S; D'Arminio Monforte A; El-Sadr W; Phillips A; Ingrid Hatleberg C; Sabin C; Mocroft A;
J Infect Dis; 2019 Oct; 220(10):1629-1634. PubMed ID: 31504669
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
Ryom L; Lundgren JD; El-Sadr W; Reiss P; Kirk O; Law M; Phillips A; Weber R; Fontas E; d' Arminio Monforte A; De Wit S; Dabis F; Hatleberg CI; Sabin C; Mocroft A;
Lancet HIV; 2018 Jun; 5(6):e291-e300. PubMed ID: 29731407
[TBL] [Abstract][Full Text] [Related]
20. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.
Scherzer R; Gandhi M; Estrella MM; Tien PC; Deeks SG; Grunfeld C; Peralta CA; Shlipak MG
AIDS; 2014 Jun; 28(9):1289-95. PubMed ID: 24922479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
